Evidence map›Paper›PMID 41155897›Full record

ArticlePharmaceutics2025

Benzoxazine-Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action.

Houria Boulaiz, Yaiza Jiménez-Martínez, Francisco Franco-Montalbán, Jesús Peña-Martín, Ana Conejo-García, M Dora Carrión

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Houria BoulaizDepartment of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0003-4433-7556
Yaiza Jiménez-MartínezBiosanitary Institute of Granada (ibs.GRANADA), SAS-University of Granada, Avenida de Madrid, 15, 18012 Granada, Spain.ORCID 0000-0003-2936-5831
Francisco Franco-MontalbánExcellence Research Unit of Chemistry Applied to Biomedicine and the Environment, Department of Medicinal and Organic Chemistry, Faculty of Pharmacy, University of Granada, Campus Cartuja s/n, 18071 Granada, Spain.ORCID 0000-0001-6539-1653
Jesús Peña-MartínBiosanitary Institute of Granada (ibs.GRANADA), SAS-University of Granada, Avenida de Madrid, 15, 18012 Granada, Spain.ORCID 0000-0002-5525-2657
Ana Conejo-GarcíaBiosanitary Institute of Granada (ibs.GRANADA), SAS-University of Granada, Avenida de Madrid, 15, 18012 Granada, Spain.ORCID 0000-0001-5776-7315
M Dora CarriónBiosanitary Institute of Granada (ibs.GRANADA), SAS-University of Granada, Avenida de Madrid, 15, 18012 Granada, Spain.ORCID 0000-0002-6794-3949

Funding

MICIU/AEI/https://doi.org/10.13039/501100011033 and for FEDER, UE PID2021.128109OB.I00Public-Private Collaboration Research and Innovation/Junta de Andalucía Consejería de Economía y Conocimiento PIP-0173-2022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancer activityapoptosis and pyroptosisbenzoxazineskinases inhibitionpurines

Identifiers

PMID41155897
PMCPMC12567375

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.